Login / Signup
Sabrina Calil-Elias
ORCID
Publication Activity (10 Years)
Years Active: 2019-2023
Publications (10 Years): 3
Top Topics
Mesenchymal Stem Cells
Patient Safety
Health Promotion
Adverse Drug
Top Venues
Revista de saude publica
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Pharmacoepidemiology and drug safety
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Evani Leite de Freitas
,
Sabrina Calil-Elias
,
Rafael Santos Erbisti
,
Branca Grinberg-Weller
,
Elaine Silva Miranda
Consumption of drugs for Alzheimer's disease on the Brazilian private market.
Revista de saude publica
57 (2023)
Renata Rv Cataldo
,
Liliane Ar Manaças
,
Priscila Hm Figueira
,
Carla Vg Ferraz
,
Sabrina Calil-Elias
Use of therapeutic outcomes monitoring method for performing of pharmaceutical care in oncology patients.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
(2021)
Camille Nigri Cursino
,
Priscilla Garcia de Oliveira Monteiro
,
Gabriel da Silva Duarte
,
Tassita Bezz Quintanilha Vieira
,
Verônica de Carvalho Crisante
,
Fabíola Giordani
,
Ana Lucia Rampazzo Xavier
,
Renan Moritz Varnier Rodrigues de Almeida
,
Sabrina Calil-Elias
Predictors of adverse drug reactions associated with ribavirin in direct-acting antiviral therapies for chronic hepatitis C.
Pharmacoepidemiology and drug safety
28 (12) (2019)